DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders
DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at Mizuho to a "strong-buy" rating.
The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM [CNET News]
FDA Approves New DexCom Diabetes Device [Yahoo! Finance]